Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the <scp>ROTATE</scp> trials-Reference-Cited by-同舟云学术

Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

Published:2023-05-11 Issue:8 Volume:25 Page:2413-2418
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Sen Taha¹^ORCID,Curovic Viktor Rotbain²^ORCID,Jongs Niels¹^ORCID,Laverman Gozewijn D.³,Kooy Adriaan⁴^ORCID,Persson Frederik²^ORCID,Rossing Peter²^ORCID,Heerspink Hiddo J. L.¹⁵^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology University of Groningen, University Medical Centre Groningen Groningen The Netherlands

2. Steno Diabetes Centre Copenhagen Herlev Denmark

3. ZiekenhuisGroep Twente Almelo The Netherlands

4. Bethesda Diabetes Research Centre Hoogeveen The Netherlands

5. The George Institute for Global Health UNSW Sydney Sydney New South Wales Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Diabetic nephropathy and inflammation

2. Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance

3. The Effect of Angiotensin II Receptor Blockade on an End-Stage Renal Failure Model of Type 2 Diabetes

4. Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation

5. Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance;Journal of Diabetes and its Complications;2023-08